Pathway Financial Advisers, LLC Astrazeneca PLC Transaction History
Pathway Financial Advisers, LLC
- $292 Million
- Q4 2024
A detailed history of Pathway Financial Advisers, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Pathway Financial Advisers, LLC holds 284 shares of AZN stock, worth $22,038. This represents 0.01% of its overall portfolio holdings.
Number of Shares
284
Previous 284
-0.0%
Holding current value
$22,038
Previous $22.1 Million
99.92%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding AZN
# of Institutions
1,367Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.68 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.18 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.91 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.87 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.86 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $240B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...